Gergely Buglyó
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Extracellular vesicles in disease
- Circular RNAs in diseases
- RNA modifications and cancer
- Renal and related cancers
Papers in
-
- Cancer Genomics and Diagnostics 5
- MicroRNA in disease regulation 5
- Cancer-related molecular mechanisms research 3
- Urology 2
- Co-authors
- Bálint NagyTomáš SzemesOndrej PösJán RadvánszkyZuzana PösBeáta SoltészMelinda SzilágyiAndrás Penyige
In The Last Decade
Gergely Buglyó
19 papers receiving 457 citations
Hit Papers
Peers
Comparison fields: 5 of 68
- Cancer Research 209
- Molecular Biology 287
- Genetics 103
- Oncology 55
- Pathology and Forensic Medicine 34
Countries citing papers authored by Gergely Buglyó
This map shows the geographic impact of Gergely Buglyó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gergely Buglyó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gergely Buglyó more than expected).
Fields of papers citing papers by Gergely Buglyó
This network shows the impact of papers produced by Gergely Buglyó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gergely Buglyó. The network helps show where Gergely Buglyó may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gergely Buglyó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 11 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 12 | |
| 9 | 2021 | 38 | |
| 10 | DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects Hit paper breakdown → | 2021 | 135 |
| 11 | 2021 | 39 | |
| 12 | 2021 | 7 | |
| 13 | 2020 | 140 | |
| 14 | 2019 | 11 | |
| 15 | 2018 | 1 | |
| 16 | 2017 | 3 | |
| 17 | 2015 | 19 | |
| 18 | 2013 | 12 | |
| 19 | 2012 | 1 |
About Gergely Buglyó
Gergely Buglyó is a scholar working on Cancer Research, Urology, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 19 papers that have together received 463 indexed citations. Recurring topics across this work include Renal and related cancers (8 papers), Cancer Genomics and Diagnostics (5 papers), MicroRNA in disease regulation (5 papers), Extracellular vesicles in disease (3 papers), Circular RNAs in diseases (3 papers), Cancer-related molecular mechanisms research (3 papers), Genetic factors in colorectal cancer (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (209 citations), Molecular Biology (287 citations), Genetics (103 citations), Oncology (55 citations) and Pathology and Forensic Medicine (34 citations). Gergely Buglyó has collaborated with scholars based in Hungary and Slovakia. Frequent co-authors include Bálint Nagy, Tomáš Szemes, Ondrej Pös, Ján Radvánszky, Zuzana Pös, Beáta Soltész, Melinda Szilágyi, András Penyige, Éva Márton and Sándor Bíró. Their work appears in journals such as International Journal of Molecular Sciences, Cancers, Pathology & Oncology Research, Biomedical Journal and Applied Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.